Compound class:
Synthetic organic
Comment: PL37 is an investigational, orally available, dual pro-drug inhibitor of neprilysin (a.k.a. neutral endopeptidase or NEP; MME) and aminopeptidase N (APN; ANPEP) [3]. NEP and APN are enkephalin catabolising enzymes (or enkephalinases). Dual ENKephalinase inhibitors such as this one have been ascribed the acronym DENK inhibitor (or DENKi).
PL37 is the non-stereo enantiomer of compound 15 in patent US8247609 [4]. Such dual inhibitors are suggested as a novel mechanism for the control of central and peripheral pain [5], via inhibition of enzymatic degradation of endogenous enkephalins. Such agents could replace the use of opiate analgesics. |
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
1-ethoxycarbonyloxyethyl 2-[[2-[(2-amino-4-methylsulfanylbutyl)disulfanylmethyl]-3-phenylpropanoyl]amino]acetate |
Synonyms ![]() |
|
19-IIIa [3] | Debio 0827 [1] | Debio-0827 |
Database Links ![]() |
|
GtoPdb PubChem SID | 315661093 |
PubChem CID | 16123252 |
Search Google for chemical match using the InChIKey | BJCNUZJDFWFVBY-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | BJCNUZJDFWFVBY |
UniChem Compound Search for chemical match using the InChIKey | BJCNUZJDFWFVBY-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | BJCNUZJDFWFVBY-UHFFFAOYSA-N |